Carisoprodol
Product Images NDC 10544-088

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 10544-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

350mg 30ct (Label Carisoprodol Tabs 350mg Bpi(10544 088 30) Rising(64980 174 10) Rev2)

350mg 30ct (Label Carisoprodol Tabs 350mg Bpi(10544 088 30) Rising(64980 174 10) Rev2)
Carisoprodol Tablets, USP 350 mg, bottle label for 30 tablets by Blenheim Pharmacal, Inc. The label states Rx Only with storage instructions at 20°-25°C (68°-77°F) and to store in a tight-resistant container. Federal law caution on drug transfer is noted. The label includes barcodes, lot number, expiration date fields, and manufacturer information in North Bergen, NJ.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram showing the molecular formula of carisoprodol, depicting its functional groups and atomic connectivity as typically found in chemical representations of carisoprodol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.